Funded Tech Companies
Envisagenics
Operating out of New York, Envisagenics has funding from National Institutes of Health, Third Kind Venture Capital and Bristol Myers Squibb.
Company Overview
Company Name
Envisagenics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
101 Ave. of the Americas 3rd Floor
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Website
Email Address
Company Background Information
Overview
Envisagenics is a New York City-based a bioinformatics company. Biomedical data might hold the key to finding the cure for currently incurable diseases. Our mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/13/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Pineda
Chief Technical Officer
Martin Akerman
Company Investors
- National Institutes of Health
- Third Kind Venture Capital
- Bristol Myers Squibb
- Red Cell Partners (Grant Verstandig)
- Empire State Development
- M12
- Madrona Venture Group
- Dynamk Capital
- New York Ventures
- Breakout Labs
Browse more funded tech companies:
Envisage Technologies | Envisia Therapeutics
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs